Conditions: Hepatic Impairment
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 24
Healthy volunteers: yes

Brief summary:
The purpose of the protocol is to assess the pharmacokinetics, safety and tolerability of a single dose of telotristat etiprate in subjects with various stages of hepatic impairment compared to healthy control subjects.

Detailed description:

Arms:
arm 1: 1 single oral dose (2 x 250-mg tablets)

Interventions: intervention 1: telotristat etiprate
Intervention descriptions: intervention 1: None

Protocol document: